Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.292
$0.0020.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.32% | 8.37% | 35.42% | -16.98% | 175.96% |
| Total Receivables | 20.15% | -3.58% | -6.06% | -1.08% | 26.41% |
| Inventory | -8.94% | -1.41% | -0.18% | 0.67% | -8.07% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.54% | -7.87% | 51.05% | -18.98% | -21.73% |
| Total Current Assets | 2.16% | -0.87% | 2.44% | -2.11% | 7.01% |
|
|
|||||
| Total Current Assets | 2.16% | -0.87% | 2.44% | -2.11% | 7.01% |
| Net Property, Plant & Equipment | -4.75% | -9.29% | -7.18% | -6.03% | 2.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.69% | -1.03% | -4.23% | -2.37% | -1.67% |
| Total Assets | -0.02% | -1.99% | -0.09% | -2.73% | 4.75% |
|
|
|||||
| Total Accounts Payable | -10.93% | 1.63% | 10.08% | -31.66% | 11.13% |
| Total Accrued Expenses | -9.26% | -22.02% | -13.12% | 14.75% | 47.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.45% | 1.05% | 0.21% | -0.10% | 0.11% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -10.65% | -7.53% | -1.54% | -11.84% | 19.06% |
|
|
|||||
| Total Current Liabilities | -10.65% | -7.53% | -1.54% | -11.84% | 19.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.66% | -40.56% | -28.61% | -22.10% | -17.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -11.14% | -10.54% | -4.82% | -13.22% | 12.24% |
|
|
|||||
| Common Stock & APIC | 0.09% | 0.12% | 0.10% | 0.11% | 0.12% |
| Retained Earnings | 1.92% | 0.36% | 0.80% | 0.82% | 0.87% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 3.33% | 0.91% | 1.62% | 1.73% | 1.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.33% | 0.91% | 1.62% | 1.73% | 1.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.33% | 0.91% | 1.62% | 1.73% | 1.86% |
|
|
|||||